FDA Approved: SIROLIMUS — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals NY LLC for an original application of sirolimus (Rapamune), a generic form of rapamycin, to prevent organ transplant rej…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Rapamune (sirolimus)

Snippet

ORIG AP for SIROLIMUS (SIROLIMUS)